Extracellular vimentin mimics VEGF and is a target for anti-angiogenic immunotherapy.
van Beijnum JR, Huijbers EJM, van Loon K, Blanas A, Akbari P, Roos A, Wong TJ, Denisov SS, Hackeng TM, Jimenez CR, Nowak-Sliwinska P, Griffioen AW.
van Beijnum JR, et al. Among authors: akbari p.
Nat Commun. 2022 May 23;13(1):2842. doi: 10.1038/s41467-022-30063-7.
Nat Commun. 2022.
PMID: 35606362
Free PMC article.